Medications

US approves highly anticipated Eli Lilly weight loss drug

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.

Health

What physicians get wrong about the risks of being overweight

Based on cues she'd picked up from popular culture and public health guidance, Stanford Medicine statistician Maya Mathur, Ph.D., had always assumed that being overweight decreases lifespans. She was surprised, then, to come ...

Oncology & Cancer

Obesity is increasing people's risk of cancer. Why?

Obesity is now a global epidemic, and it is increasing people's risk for cancer. The National Cancer Institute lists more than a dozen cancers that are associated with overweight and obesity. But how obesity increases cancer ...

Overweight & Obesity

Is child obesity really going to shorten lives?

Rising life expectancy is one of the great success stories. If you were born in 1870, you'd expect to live until you were 30. But if you were born today, you'd expect to live to 72, and the UN predicts it will continue to ...

page 2 from 40